Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of steady-state esomeprazole on single-dose telaprevir pharmacokinetics in healthy volunteers
NL-OMON31863Phase 1Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telaprevir and esomeprazole in hepatitis C virus infection (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Pharmacokinetics of telaprevir. Started Mar 2008; status: active, not recruiting.
02
Drugs
telapreviresomeprazole
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON31863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31863.